Revised Geneva Score Calculator
Calculate revised geneva score quickly with our cardiovascular system tool. Get results based on evidence-based formulas with clear explanations.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Revised Geneva Score Calculator
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser — no data is sent to any server.
Formula: Revised Geneva Score = Sum of weighted clinical variables (0-25 points)
Worked example — Score: 0/25 | Low Probability | Recommend D-dimer testing; if negative, PE excluded
Formula
Revised Geneva Score = Sum of weighted clinical variables (0-25 points)
Variables include age > 65 (+1), previous PE/DVT (+3), recent surgery/fracture (+2), active malignancy (+2), unilateral leg pain (+3), hemoptysis (+2), heart rate 75-94 (+3) or >= 95 (+5), and leg pain on palpation/unilateral edema (+4/+1). Scores 0-3 = low, 4-10 = intermediate, 11+ = high probability.
Worked Examples
Example 1: Low Probability PE Assessment
Problem:A 55-year-old patient presents with chest pain. No prior VTE history, no recent surgery, no cancer. Heart rate 70 bpm. No leg symptoms or hemoptysis.
Solution:Scoring: Age > 65: No (0 points), Previous PE/DVT: No (0), Recent surgery: No (0), Active cancer: No (0), Unilateral leg pain: No (0), Hemoptysis: No (0), Heart rate 70 < 75: (0 points), Leg palpation pain/edema: No (0). Total Revised Geneva Score = 0 Probability category: Low (0-3 points) PE prevalence in this group: approximately 8%
Result:Score: 0/25 | Low Probability | Recommend D-dimer testing; if negative, PE excluded
Example 2: High Probability PE Assessment
Problem:A 72-year-old patient with prior DVT, active lung cancer, heart rate 100 bpm, unilateral leg swelling with pain on palpation, and recent hemoptysis.
Solution:Scoring: Age > 65: Yes (+1), Previous PE/DVT: Yes (+3), Recent surgery: No (0), Active cancer: Yes (+2), Unilateral leg pain: Yes (+3), Hemoptysis: Yes (+2), Heart rate >= 95: (+5), Leg palpation pain + edema: Yes (+4 + 1 = +5). Total Revised Geneva Score = 1+3+2+3+2+5+5 = 21 Probability category: High (> 10 points) PE prevalence in this group: approximately 74%
Result:Score: 21/25 | High Probability | Proceed directly to CTPA; consider empiric anticoagulation
Frequently Asked Questions
What is the Revised Geneva Score and what does it assess?
The Revised Geneva Score is a validated clinical prediction rule used to estimate the pretest probability of pulmonary embolism (PE) in patients presenting with suspected PE symptoms. Originally developed in 2006 by Le Gal and colleagues, it was designed to simplify the original Geneva Score while maintaining diagnostic accuracy. The score uses eight clinical variables that are entirely objective, meaning they do not require subjective clinical assessment. This objectivity is a major advantage over the Wells Score, which includes a somewhat subjective criterion. The Revised Geneva Score stratifies patients into low, intermediate, and high probability categories, guiding subsequent diagnostic workup decisions including D-dimer testing and CT pulmonary angiography.
How does the Revised Geneva Score differ from the Wells Score for PE?
Both the Revised Geneva Score and the Wells Score are clinical prediction rules for pulmonary embolism, but they differ in important ways. The Wells Score includes a subjective criterion asking whether PE is the most likely diagnosis, which can introduce variability between clinicians. The Revised Geneva Score uses only objective, standardized variables, making it more reproducible across different healthcare providers and settings. The Wells Score uses a two-tier (PE likely/unlikely) or three-tier (low/moderate/high) system, while the Revised Geneva Score uses three probability levels. Studies comparing both scores show similar overall diagnostic accuracy, with c-statistics around 0.70 to 0.75 for each. Many clinicians prefer the Revised Geneva Score for research settings due to its objectivity, while the Wells Score remains popular in clinical practice.
What clinical variables are included in the Revised Geneva Score?
The Revised Geneva Score evaluates eight clinical variables. Age over 65 years adds 1 point. Previous history of pulmonary embolism or deep vein thrombosis adds 3 points. Surgery under general anesthesia or lower limb fracture within the past month adds 2 points. Active malignant condition (solid or hematologic, currently active or considered cured for less than one year) adds 2 points. Unilateral lower limb pain adds 3 points. Hemoptysis (coughing up blood) adds 2 points. Heart rate between 75 and 94 beats per minute adds 3 points, while a heart rate of 95 or above adds 5 points. Pain on lower limb deep venous palpation and unilateral edema adds 4 points. The maximum possible score is 25 points.
How should D-dimer testing be interpreted alongside the Geneva Score results?
D-dimer testing plays a crucial role in the diagnostic algorithm when combined with the Revised Geneva Score. For patients with a low probability score (0 to 3 points), a negative D-dimer test can safely exclude pulmonary embolism without further imaging, as the negative predictive value exceeds 99 percent in this group. For intermediate probability patients (4 to 10 points), D-dimer testing is recommended as the next step because imaging all these patients would be costly and expose many to unnecessary radiation. A positive D-dimer in this group warrants CT pulmonary angiography. For high probability patients (11 or more points), D-dimer testing is generally not recommended because the clinical suspicion is high enough to warrant direct imaging, and a negative D-dimer cannot reliably exclude PE in this group.
What are the limitations of the Revised Geneva Score in clinical practice?
The Revised Geneva Score has several important limitations that clinicians should understand. It was primarily validated in emergency department populations and may not perform as well in outpatient or critically ill inpatient settings. The score does not account for certain risk factors such as hormonal contraceptive use, recent long-distance travel, thrombophilia, or obesity, which can influence PE probability. In pregnant patients, the score has not been adequately validated and should be used with extreme caution. The score may also underestimate risk in younger patients with significant risk factors because age contributes only one point. Additionally, the heart rate criterion can be affected by medications such as beta-blockers or conditions causing tachycardia unrelated to PE, potentially leading to misclassification.
What is the clinical significance of pulmonary embolism risk stratification?
Risk stratification for pulmonary embolism is critically important because PE is both common and potentially fatal, with untreated massive PE having mortality rates exceeding 25 percent. However, the symptoms of PE are nonspecific and overlap with many other conditions including pneumonia, heart failure, musculoskeletal pain, and anxiety. Without structured risk stratification tools like the Revised Geneva Score, clinicians face a dilemma: overtesting leads to unnecessary radiation exposure, false positives, incidental findings, and healthcare costs, while undertesting risks missing a life-threatening diagnosis. Studies show that using validated clinical prediction rules combined with D-dimer testing can safely reduce CT pulmonary angiography utilization by 30 to 40 percent without missing clinically significant PE cases. This structured approach improves both patient safety and resource utilization.
How does heart rate influence the Revised Geneva Score and why is it weighted heavily?
Heart rate is one of the most heavily weighted variables in the Revised Geneva Score, contributing up to 5 points for rates at or above 95 beats per minute. This heavy weighting reflects the strong physiological relationship between pulmonary embolism and tachycardia. When a blood clot obstructs pulmonary arteries, the right ventricle must work harder to pump blood through the remaining patent vessels, leading to increased heart rate as a compensatory mechanism. Additionally, PE triggers sympathetic nervous system activation due to hypoxemia and hemodynamic stress. Research shows that tachycardia is present in approximately 40 to 50 percent of patients with confirmed PE, making it one of the most common clinical signs. However, clinicians must recognize that tachycardia has many causes, and its presence alone is neither sensitive nor specific enough for PE diagnosis.
Can the Revised Geneva Score be used in hospitalized patients or only in the emergency department?
The Revised Geneva Score was primarily developed and validated in emergency department populations presenting with symptoms suggestive of pulmonary embolism. Its application in hospitalized patients requires careful consideration. Inpatients may have different baseline characteristics, including altered heart rates due to medications, immobility-related risk factors, and multiple comorbidities that can confound the score interpretation. Several studies have attempted to validate the score in inpatient settings with mixed results, generally showing lower discriminatory ability compared to ED populations. For hospitalized patients who develop new symptoms concerning for PE, the score can still provide a structured framework for risk assessment, but clinicians should have a lower threshold for proceeding to imaging. The YEARS algorithm and PERC criteria are alternative approaches that some institutions prefer for inpatient PE evaluation.
What is the simplified version of the Revised Geneva Score?
The simplified Revised Geneva Score was developed to make bedside calculation easier by assigning one point for each variable present instead of the weighted scoring in the original version. In the simplified version, each of the eight criteria receives exactly one point: age over 65, previous PE or DVT, surgery or fracture within one month, active malignancy, unilateral leg pain, hemoptysis, heart rate 75 to 94 (1 point) or 95 and above (1 point), and pain on deep vein palpation with unilateral edema. Low probability is defined as 0 to 1 points, intermediate as 2 to 4, and high as 5 or more. Validation studies have shown that the simplified version performs comparably to the original weighted version, with similar sensitivity, specificity, and failure rates. Its main advantage is ease of use, as clinicians do not need to remember different point values for each variable.
What happens after a patient is classified as high probability by the Revised Geneva Score?
When a patient receives a high probability classification (score of 11 or more points) on the Revised Geneva Score, immediate action is required given the approximately 74 percent prevalence of PE in this group. The recommended approach is to proceed directly to CT pulmonary angiography without waiting for D-dimer results, as even a negative D-dimer cannot reliably exclude PE at this probability level. While awaiting imaging, many guidelines recommend initiating empiric anticoagulation with unfractionated heparin or low-molecular-weight heparin unless there are absolute contraindications such as active major bleeding. If CTPA is contraindicated or unavailable, ventilation-perfusion scanning or lower extremity ultrasonography can be used as alternative diagnostic strategies. For hemodynamically unstable patients with high clinical suspicion, bedside echocardiography can provide rapid assessment of right ventricular dysfunction.
References
- Le Gal G et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score - Annals of Internal Medicine 2006
- Klok FA et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism - Archives of Internal Medicine 2008
- Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮AUDIT Score Calculator
Calculate audit score with inputs, formulas, and instant results.
🧮Duke Treadmill Score Calculator
Calculate duke treadmill score with inputs, formulas, and instant results.
🧮Padua Score Calculator
Calculate padua score with inputs, formulas, and instant results.
🧮Diet Risk Score Calculator
Calculate diet risk score with inputs, formulas, and instant results.
🧮Bishop Score Calculator
Calculate bishop score with inputs, formulas, and instant results.
🧮Vterisk Score Calculator in Pregnancy
Calculate vterisk score in pregnancy with inputs, formulas, and instant results.
🧮Apgar Score Calculator
Calculate the Apgar score for newborn health assessment at 1 and 5 minutes after birth.
🧮Menopause Symptom Score Calculator
Score menopause symptom severity using the Menopause Rating Scale questionnaire.